Cidara Therapeutics (CDTX) Misses Q4 EPS by 537c
Tweet
Share
E-mailGet Alerts CDTX Hot Sheet
Join SI Premium – FREE
Cidara Therapeutics (NASDAQ: CDTX) reported Q4 EPS of ($5.37).
For earnings history and earnings-related data on Cidara Therapeutics (CDTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA maintains underperform ratings on six BDC stocks
- Wolfe Research sees CNH stock flat 2027 outlook on commodity prices
- Boeing names Ryan Shedd as new SVP and controller
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
